StocksFundsScreenerSectorsWatchlists
GMRE

GMRE - Global Medical REIT Inc Stock Price, Fair Value and News

8.77USD+0.17 (+1.98%)Delayed as of 28 Mar 2024, 11:00 am ET

Market Summary

GMRE
USD8.77+0.17
Delayedas of 28 Mar 2024, 11:00 am
1.98%

GMRE Alerts

  • Big fall in earnings (Y/Y)

GMRE Stock Price

View Fullscreen

GMRE RSI Chart

GMRE Valuation

Market Cap

563.9M

Price/Earnings (Trailing)

25.95

Price/Sales (Trailing)

4

Price/Free Cashflow

8.24

GMRE Price/Sales (Trailing)

GMRE Profitability

Return on Equity

3.72%

Return on Assets

1.71%

Free Cashflow Yield

12.14%

GMRE Fundamentals

GMRE Revenue

Revenue (TTM)

141.0M

Rev. Growth (Yr)

-9.21%

Rev. Growth (Qtr)

-7.17%

GMRE Earnings

Earnings (TTM)

21.7M

Earnings Growth (Yr)

-70.18%

Earnings Growth (Qtr)

-88.6%

Breaking Down GMRE Revenue

52 Week Range

8.0610.45
(Low)(High)

Last 7 days

-4.7%

Last 30 days

-13.0%

Last 90 days

-27.6%

Trailing 12 Months

-5.1%

How does GMRE drawdown profile look like?

GMRE Financial Health

Current Ratio

0.16

GMRE Investor Care

Dividend Yield

9.77%

Dividend/Share (TTM)

0.84

Shares Dilution (1Y)

0.07%

Diluted EPS (TTM)

0.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023141.6M144.3M144.4M141.0M
2022120.5M125.9M131.3M137.3M
202199.4M105.6M110.5M115.9M
202077.2M82.4M89.3M93.7M
201956.8M60.5M64.7M70.7M
201837.3M43.1M48.7M53.2M
201711.6M17.2M23.6M30.3M
20162.9M4.2M5.7M8.2M
20151.9M2.0M2.0M2.1M
201400380.4K1.1M

Tracking the Latest Insider Buys and Sells of Global Medical REIT Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 30, 2023
moore roscoe m jr
acquired
-
-
7,412
-
Jan 10, 2023
moore roscoe m jr
sold
-48,956
9.7913
-5,000
-
Mar 29, 2022
moore roscoe m jr
acquired
-
-
5,000
-
Mar 04, 2022
cole henry
bought
19,999
15.5396
1,287
-
Mar 03, 2022
busch jeffrey
bought
31,100
15.55
2,000
chairman, president and ceo
Aug 19, 2021
busch jeffrey
bought
15,010
15.01
1,000
chairman, president and ceo
Mar 08, 2021
busch jeffrey
bought
24,167
13.81
1,750
chairman, president and ceo
Aug 12, 2020
marston ronald
bought
26,600
13.3
2,000
-
Aug 07, 2020
busch jeffrey
bought
133,900
13.39
10,000
chairman, president and ceo
Mar 12, 2020
cole henry
bought
19,978
10.8581
1,840
-

1–10 of 16

Which funds bought or sold GMRE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
unchanged
-
11,274
58,752
-%
Mar 15, 2024
B. Riley Wealth Advisors, Inc.
reduced
-23.66
-46,519
735,344
0.02%
Mar 11, 2024
VANGUARD GROUP INC
added
1.27
13,762,900
68,122,200
-%
Mar 01, 2024
Creekmur Asset Management LLC
new
-
91,857
91,857
0.03%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
63.8
2,382,160
4,701,830
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
63,500
336,663
-%
Feb 22, 2024
AUXIER ASSET MANAGEMENT
sold off
-100
-107,640
-
-%
Feb 20, 2024
Quarry LP
sold off
-100
-14,827
-
-%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
1,917
9,990
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
6.59
40,000
164,000
-%

1–10 of 48

Are Funds Buying or Selling GMRE?

Are funds buying GMRE calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own GMRE
No. of Funds

Unveiling Global Medical REIT Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.36%
6,137,137
SC 13G/A
Jan 25, 2024
blackrock inc.
8.0%
5,241,267
SC 13G/A
Feb 09, 2023
vanguard group inc
9.79%
6,416,884
SC 13G/A
Jan 31, 2023
blackrock inc.
7.7%
5,035,110
SC 13G/A
Feb 03, 2022
blackrock inc.
7.6%
4,863,718
SC 13G
Feb 10, 2021
vanguard group inc
9.01%
4,343,493
SC 13G/A
Jan 29, 2021
blackrock inc.
7.1%
3,410,573
SC 13G/A
Mar 06, 2020
vanguard group inc
10.00%
4,290,304
SC 13G/A
Feb 11, 2020
vanguard group inc
9.86%
4,231,145
SC 13G
Feb 07, 2020
blackrock inc.
6.1%
2,602,565
SC 13G

Recent SEC filings of Global Medical REIT Inc

View All Filings
Date Filed Form Type Document
Mar 05, 2024
8-K
Current Report
Feb 29, 2024
POS AM
POS AM
Feb 28, 2024
10-K
Annual Report
Feb 27, 2024
POSASR
POSASR
Feb 27, 2024
8-K
Current Report
Feb 27, 2024
424B5
Prospectus Filed
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading

Peers (Alternatives to Global Medical REIT Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
92.0B
11.1B
3.02% 3.17%
67.33
8.26
4.04% -19.43%
45.8B
7.0B
-5.01% -21.08%
30.53
6.57
-0.07% -10.36%
26.1B
2.8B
3.42% 11.05%
28.1
9.43
6.73% -18.30%
21.9B
2.9B
5.24% -2.41%
211.79
7.61
11.46% -80.13%
13.1B
1.6B
5.52% 21.06%
30.39
8.17
7.80% 39.39%
11.1B
1.3B
-2.42% 1.98%
30.46
8.4
8.04% -24.50%
9.9B
3.3B
-6.07% 8.98%
52.15
3.03
5.31% -77.32%
MID-CAP
8.4B
1.1B
-0.89% 2.72%
35.55
7.44
5.38% -38.52%
3.7B
884.1M
-1.28% 51.03%
-13.45
4.17
2.90% -314.82%
3.5B
899.4M
12.83% 136.94%
-6.17
3.87
-0.45% -623.11%
SMALL-CAP
1.3B
441.2M
-3.35% 20.98%
20.37
2.99
4.38% 15.77%
1.2B
198.2M
4.31% 1.50%
-7.47
5.93
-43.33% -270.70%
1.1B
605.6M
5.98% 19.45%
14.31
1.89
25.53% 134.62%
650.5M
258.7M
-8.43% -22.26%
-13.37
2.51
0.11% 83.70%
461.8M
277.9M
8.28% -16.39%
-29.12
1.66
44.33% 96.06%

Global Medical REIT Inc News

Latest updates
InvestorsObserver • 29 minutes ago
MarketBeat • 19 Mar 2024 • 10:34 am
MarketBeat • 09 Mar 2024 • 02:40 pm
Yahoo Finance • 01 Mar 2024 • 08:00 am
Seeking Alpha • 29 Feb 2024 • 08:00 am

Global Medical REIT Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-7.2%33.0036.0036.0036.0036.0035.0034.0032.0030.0030.0028.0027.0025.0025.0022.0022.0020.0018.0017.0015.0014.00
Operating Expenses-4.3%32.0033.0035.0035.0034.0032.0030.0028.0026.0025.0024.0024.0022.0035.0020.0019.0018.0016.0014.0013.0013.00
  S&GA Expenses-3.4%4.004.004.004.004.004.004.004.004.004.004.004.004.004.002.002.002.002.002.002.001.00
Interest Expenses-2.6%7.007.008.008.008.007.005.005.005.005.005.005.005.005.004.004.005.005.004.004.004.00
Net Income-88.6%1.005.0014.002.002.0010.004.004.005.005.004.003.003.00-9.582.003.003.002.002.002.0010.00
Net Income Margin-3.4%0.15*0.16*0.20*0.13*0.15*0.18*0.15*0.16*0.16*0.14*0.00*-0.02*---------
Free Cashflow8.8%18.0017.0018.0016.0018.0018.0023.0016.0017.0019.0018.0015.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-2.7%1,2681,3031,3211,3691,3931,4071,3571,2851,2631,2431,2001,1361,1011,026967956885812751657636
    Cash Equivalents-0.2%1.001.002.005.004.003.006.002.0013.006.006.005.0011.002.008.0011.007.003.003.003.005.00
  Goodwill0%6.006.006.006.006.006.006.006.006.006.006.006.006.006.006.00------
Liabilities-1.0%662669679741744742708633626613563540643576524517425441389286336
Shareholder's Equity-4.6%584611641628633665649653638630637596458449443439460371362371300
  Retained Earnings-6.5%-238-224-213-211-198-185-179-168-157-147-138-127-116-107-88.04-78.99-71.39-63.85-57.40-51.39-45.01
  Additional Paid-In Capital0%722722722722722722722720711700700649505487463440433340323322243
Shares Outstanding0%66.0066.0066.0066.0066.0065.0066.0065.0061.0059.0057.0053.00---------
Minority Interest0.1%22.0022.0022.0016.0016.0016.0015.0015.0015.0015.0014.0014.0013.0015.0015.0023.0030.0030.0030.0030.0030.00
Float---564---693---892---481---324--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations8.8%18,12516,66617,87815,77118,30818,31423,48316,43617,28318,60817,78915,28716,131-5,47911,60812,2609,74610,01710,5166,1485,734
  Share Based Compensation3.1%1,2221,1851,1476881,0661,0391,2891,2871,2421,2411,6121,7151,9281,572897922843868854771693
Cashflow From Investing-155.0%-3,1145,66461,9743,092-1,410-33,448-75,798-26,596-27,925-50,769-72,399-43,572-82,060-65,653-7,196-68,763-75,523-65,200-94,819-22,655-15,187
Cashflow From Financing35.1%-15,899-24,503-84,048-19,337-16,03814,52958,3255,59111,53231,66055,58028,93269,42065,057-7,95166,19467,13655,13786,86714,97210,474
  Dividend Payments0.1%1,4561,4551,4561,4551,4561,4551,4561,4551,4561,4551,4561,4551,4561,455-2,9111,4571,4541,4561,4551,455

GMRE Income Statement

2023-12-31
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue   
Rental revenue$ 140,934$ 137,167$ 115,804
Other income115116132
Total revenue141,049137,283115,936
Expenses   
General and administrative16,85316,54516,453
Operating expenses28,08225,18815,488
Depreciation expense41,26640,00833,825
Amortization expense16,86916,71513,050
Interest expense30,89325,23019,696
Preacquisition expense44354151
Total expenses134,007124,04098,663
Income before gain on sale of investment property7,04213,24317,273
Gain on sale of investment property15,5606,7531,069
Loss on extinguishment of debt(868)00
Net income21,73419,99618,342
Less: Preferred stock dividends(5,822)(5,822)(5,822)
Less: Net income attributable to noncontrolling interest(1,122)(854)(720)
Net income (loss) attributable to common stockholders$ 14,790$ 13,320$ 11,800
Net income (loss) attributable to common stockholders per share - basic$ 0.23$ 0.20$ 0.19
Net income (loss) attributable to common stockholders per share - diluted$ 0.23$ 0.20$ 0.19
Weighted average shares outstanding - basic65,55065,46260,640
Weighted average shares outstanding - diluted65,55065,46260,640

GMRE Balance Sheet

2023-12-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Investment in real estate:  
Land$ 164,315$ 168,308
Building1,035,7051,079,781
Site improvements21,97422,024
Tenant improvements66,35865,987
Acquired lease intangible assets138,617148,077
Investment in real estate, Total1,426,9691,484,177
Less: accumulated depreciation and amortization(247,503)(198,218)
Investment in real estate, net1,179,4661,285,959
Cash and cash equivalents1,2784,016
Restricted cash5,44610,439
Tenant receivables, net6,7628,040
Escrow deposits6737,833
Deferred assets27,13229,616
Derivative asset25,12534,705
Goodwill5,9035,903
Other Assets15,7226,550
Total assets1,267,7001,393,261
Liabilities:  
Credit Facility, net of unamortized debt issuance costs of $7,067 and $9,253 at December 31, 2023 and December 31, 2022, respectively585,333636,447
Notes payable, net of unamortized debt issuance costs of $66 and $452 at December 31, 2023 and December 31, 2022, respectively25,89957,672
Accounts payable and accrued expenses12,78113,819
Dividends payable16,13415,821
Security deposits3,6885,461
Other liabilities12,7707,363
Acquired lease intangible liability, net5,2817,613
Total liabilities661,886744,196
Commitments and Contingencies
Equity:  
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at December 31, 2023 and December 31, 2022, respectively (liquidation preference of $77,625 at December 31, 2023 and December 31, 2022, respectively)74,95974,959
Common stock, $0.001 par value, 500,000 shares authorized; 65,565 shares and 65,518 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively6666
Additional paid-in capital722,418721,991
Accumulated deficit(238,984)(198,706)
Accumulated other comprehensive income (loss)25,12534,674
Total Global Medical REIT Inc. stockholders' equity583,584632,984
Noncontrolling interest22,23016,081
Total equity605,814649,065
Total liabilities and equity1,267,7001,393,261
Related Party [Member]  
Investment in real estate:  
Due from related parties193200
Liabilities:  
Other liabilities$ 0$ 0
GMRE
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
 CEO
 WEBSITEwww.globalmedicalreit.com
 EMPLOYEES29

Global Medical REIT Inc Frequently Asked Questions


What is the ticker symbol for Global Medical REIT Inc? What does GMRE stand for in stocks?

GMRE is the stock ticker symbol of Global Medical REIT Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Global Medical REIT Inc (GMRE)?

As of Wed Mar 27 2024, market cap of Global Medical REIT Inc is 563.94 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GMRE stock?

You can check GMRE's fair value in chart for subscribers.

What is the fair value of GMRE stock?

You can check GMRE's fair value in chart for subscribers. The fair value of Global Medical REIT Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Global Medical REIT Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GMRE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Global Medical REIT Inc a good stock to buy?

The fair value guage provides a quick view whether GMRE is over valued or under valued. Whether Global Medical REIT Inc is cheap or expensive depends on the assumptions which impact Global Medical REIT Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GMRE.

What is Global Medical REIT Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, GMRE's PE ratio (Price to Earnings) is 25.95 and Price to Sales (PS) ratio is 4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GMRE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Global Medical REIT Inc's stock?

In the past 10 years, Global Medical REIT Inc has provided 0.311 (multiply by 100 for percentage) rate of return.